EFFICACY AND SAFETY OF LONG-TERM ADMINISTRATION OF PEMAFIBRATE, A NOVEL HYPOTRIGLYCERIDEMIC AGENT, IN JAPANESE TYPE 2 DIABETIC PATIENTS RECEIVING A STATIN-MedSci.cn

EFFICACY AND SAFETY OF LONG-TERM ADMINISTRATION OF PEMAFIBRATE, A NOVEL HYPOTRIGLYCERIDEMIC AGENT, IN JAPANESE TYPE 2 DIABETIC PATIENTS RECEIVING A STATIN

Kusunoki, M; Wakazono, N; Matsuda, S; Hisano, F; Miyata, T

ATHEROSCLEROSIS, 2022; 355 (): E267

科室
- - 订阅+
  - 更多科室
工具
服务